| Product Code: ETC7664312 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Israel continues to rely on key countries such as Switzerland, USA, Germany, China, and Belgium for importing vaccine adjuvants in 2024. Despite a high concentration of market share, the industry experienced a decline in CAGR from 2020-24. However, there was a positive growth rate in 2024, indicating a potential rebound. The consistent import activity from these top exporting countries highlights the importance of international partnerships in ensuring a stable supply chain for essential healthcare products like vaccine adjuvants.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Vaccine Adjuvants Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Vaccine Adjuvants Market Revenues & Volume, 2022 & 2032F |
3.3 Israel Vaccine Adjuvants Market - Industry Life Cycle |
3.4 Israel Vaccine Adjuvants Market - Porter's Five Forces |
3.5 Israel Vaccine Adjuvants Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Israel Vaccine Adjuvants Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.7 Israel Vaccine Adjuvants Market Revenues & Volume Share, By Administration, 2022 & 2032F |
4 Israel Vaccine Adjuvants Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing government focus on vaccination programs in Israel |
4.2.2 Growing awareness about the importance of vaccines for public health |
4.2.3 Rising prevalence of infectious diseases in Israel |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for vaccine adjuvants in Israel |
4.3.2 High cost associated with research and development of new vaccine adjuvants |
5 Israel Vaccine Adjuvants Market Trends |
6 Israel Vaccine Adjuvants Market, By Types |
6.1 Israel Vaccine Adjuvants Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Vaccine Adjuvants Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 Israel Vaccine Adjuvants Market Revenues & Volume, By Particulate, 2022 - 2032F |
6.1.4 Israel Vaccine Adjuvants Market Revenues & Volume, By Pathogen, 2022 - 2032F |
6.1.5 Israel Vaccine Adjuvants Market Revenues & Volume, By Adjuvant emulsion, 2022 - 2032F |
6.1.6 Israel Vaccine Adjuvants Market Revenues & Volume, By Combination, 2022 - 2032F |
6.1.7 Israel Vaccine Adjuvants Market Revenues & Volume, By Others, 2022 - 2032F |
6.2 Israel Vaccine Adjuvants Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Vaccine Adjuvants Market Revenues & Volume, By Infectious diseases, 2022 - 2032F |
6.2.3 Israel Vaccine Adjuvants Market Revenues & Volume, By Cancer, 2022 - 2032F |
6.2.4 Israel Vaccine Adjuvants Market Revenues & Volume, By Others, 2022 - 2032F |
6.3 Israel Vaccine Adjuvants Market, By Administration |
6.3.1 Overview and Analysis |
6.3.2 Israel Vaccine Adjuvants Market Revenues & Volume, By Intramuscular, 2022 - 2032F |
6.3.3 Israel Vaccine Adjuvants Market Revenues & Volume, By Intradermal, 2022 - 2032F |
6.3.4 Israel Vaccine Adjuvants Market Revenues & Volume, By Intranasal, 2022 - 2032F |
6.3.5 Israel Vaccine Adjuvants Market Revenues & Volume, By Oral, 2022 - 2032F |
6.3.6 Israel Vaccine Adjuvants Market Revenues & Volume, By Others, 2022 - 2032F |
7 Israel Vaccine Adjuvants Market Import-Export Trade Statistics |
7.1 Israel Vaccine Adjuvants Market Export to Major Countries |
7.2 Israel Vaccine Adjuvants Market Imports from Major Countries |
8 Israel Vaccine Adjuvants Market Key Performance Indicators |
8.1 Percentage increase in vaccination coverage rates in Israel |
8.2 Number of clinical trials for vaccine adjuvants conducted in Israel |
8.3 Adoption rate of new vaccine adjuvants in the Israeli healthcare system |
8.4 Research and development investment in vaccine adjuvants in Israel |
9 Israel Vaccine Adjuvants Market - Opportunity Assessment |
9.1 Israel Vaccine Adjuvants Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Israel Vaccine Adjuvants Market Opportunity Assessment, By Application, 2022 & 2032F |
9.3 Israel Vaccine Adjuvants Market Opportunity Assessment, By Administration, 2022 & 2032F |
10 Israel Vaccine Adjuvants Market - Competitive Landscape |
10.1 Israel Vaccine Adjuvants Market Revenue Share, By Companies, 2025 |
10.2 Israel Vaccine Adjuvants Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here